| 1 |
32147975 | The macrolide drug erythromycin does not protect the hERG channel from inhibition by thioridazine and terfenadine. | 2020 Mar |
2 |
| 2 |
24417241 | Allosteric effects of erythromycin pretreatment on thioridazine block of hERG potassium channels. | 2014 Apr |
8 |
| 3 |
21484263 | Synergic effects of β-estradiol and erythromycin on hERG currents. | 2011 May |
5 |
| 4 |
16614168 | Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin, and telithromycin based on analysis of monophasic action potential duration alternans and cardiac instability. | 2006 Jul |
1 |
| 5 |
16051125 | Exaggerated block of hERG (KCNH2) and prolongation of action potential duration by erythromycin at temperatures between 37 degrees C and 42 degrees C. | 2005 Aug |
11 |
| 6 |
15385083 | Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern. | 2004 Sep-Oct |
1 |